Recruiting Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib NCT07633626 Conditions ALK-positive Non-small Cell Lung Cancer (NSCLC), Adenocarcinoma, Adenocarcinoma of Lung, +23 more Locations Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo CTIC — Bogotá, Colombia View Trial Details
